Exploring glycosuria as a mechanism for weight and fat mass reduction. A pilot study with remogliflozin etabonate and sergliflozin etabonate in healthy obese subjects

Exploring glycosuria as a mechanism for weight and fat mass reduction. A pilot study with remogliflozin etabonate and sergliflozin etabonate in healthy obese subjects

Inhibitors of sodium-dependent glucose co-transporter 2 (SGLT2) increase glucose excretion in the urine and improve blood glucose in Type 2 diabetes mellitus. Glycosuria provides an energy and osmotic drain that could alter body composition. We therefore conducted a pilot study comparing the effects...

Full description

Bibliographic Details
Main Authors: Antonella Napolitano, Sam Miller, Peter R. Murgatroyd, Elizabeth Hussey, Robert L. Dobbins, Edward T. Bullmore, Derek J.R. Nunez
Format: Article
Language:English
Published: Elsevier 2014-03-01
Series:Journal of Clinical & Translational Endocrinology
Subjects:
SGTL-2 inhibitors
Experimental medicine
Obesity
Glycosuria
Online Access:http://www.sciencedirect.com/science/article/pii/S2214623713000033

Similar Items

Similar Items